Gyeonggi-do, South Korea

Dong-Ki Choi


Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2020)
  • Daejeon, KR (2020)

Company Filing History:


Years Active: 2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Dong-Ki Choi: Innovating Cancer Treatment through Antibody Research

Introduction

Dong-Ki Choi is a prominent inventor based in Gyeonggi-do, South Korea. With a remarkable portfolio of three patents, he has significantly contributed to the field of biomedical research, particularly in cancer treatment methodologies. His innovative approaches focus on utilizing immunoglobulin-type antibodies for therapeutic purposes.

Latest Patents

Dong-Ki Choi's latest patents demonstrate his groundbreaking work in understanding and inhibiting the roles of activated RAS proteins. One of his notable patents is a method for inhibiting intracellular activated RAS using intact immunoglobulin-type antibodies with cytosol-penetrating abilities. This method focuses on binding to activated RAS within the cytosol, providing potential avenues for cancer growth inhibition and treatment.

Another significant patent describes a method for positioning antibodies in the cytoplasm by penetrating the cell membrane, which circumvents the need for specialized protein delivery systems. This innovation enhances the treatment and diagnosis of various tumors and disease-related factors that exhibit complex protein interactions.

Career Highlights

Dong-Ki Choi is associated with Orum Therapeutics, Inc., where his research efforts have propelled advances in the treatment of complex diseases such as cancer. His dedication to improving therapeutic methods through scientific innovation showcases his role as a thought leader in the field of antibody research.

Collaborations

Choi collaborates with esteemed colleagues, including Yong-Sung Kim and Seung-Min Shin. Together, they work towards enhancing therapeutic techniques and contribute to the advancement of innovative medical solutions.

Conclusion

Dong-Ki Choi's contributions highlight the potential of immunoglobulin-type antibodies in cancer therapy. Through his patents and collaborative efforts, he continues to pave the way for innovative treatments that may transform patient outcomes in the future. His work exemplifies the critical intersection of research, innovation, and practicality in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…